CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells

被引：0
|
作者：
Jung, In-Young
Kim, Yoon-Young
Yu, Ho-Sung
Kim, Seokjoong
Thon, Jonathan N.
Lee, Jungmin
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3182
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro
    Khadijeh Alishah
    Matthias Birtel
    Elham Masoumi
    Leila Jafarzadeh
    Hamid Reza Mirzaee
    Jamshid Hadjati
    Ralf-Holger Voss
    Mustafa Diken
    Sedighe Asad
    Journal of Translational Medicine, 19
  • [2] CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
    Rupp, Levi J.
    Schumann, Kathrin
    Roybal, Kole T.
    Gate, Rachel E.
    Ye, Chun J.
    Lim, Wendell A.
    Marson, Alexander
    SCIENTIFIC REPORTS, 2017, 7
  • [3] CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
    Levi J. Rupp
    Kathrin Schumann
    Kole T. Roybal
    Rachel E. Gate
    Chun J. Ye
    Wendell A. Lim
    Alexander Marson
    Scientific Reports, 7
  • [4] CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro
    Alishah, Khadijeh
    Birtel, Matthias
    Masoumi, Elham
    Jafarzadeh, Leila
    Mirzaee, Hamid Reza
    Hadjati, Jamshid
    Voss, Ralf-Holger
    Diken, Mustafa
    Asad, Sedighe
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [5] CRISPR/Cas9-Mediated Knockout of DGK Improves Anti-Tumor Activities of Human T Cells
    Kim, Yoon-Young
    Jung, In-Young
    Yu, Ho-Sung
    Kim, Seokjoong
    Lee, Jungmin
    MOLECULAR THERAPY, 2018, 26 (05) : 55 - 55
  • [6] CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells
    Elahe Kamali
    Fatemeh Rahbarizadeh
    Zohreh Hojati
    Morten Frödin
    BMC Biotechnology, 21
  • [7] CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells
    Kamali, Elahe
    Rahbarizadeh, Fatemeh
    Hojati, Zohreh
    Frodin, Morten
    BMC BIOTECHNOLOGY, 2021, 21 (01)
  • [8] CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
    Jung, In-Young
    Kim, Yoon-Young
    Yu, Ho-Sung
    Lee, Myoungsoo
    Kim, Seokjoong
    Lee, Jungmin
    CANCER RESEARCH, 2018, 78 (16) : 4692 - 4703
  • [9] CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells
    Chun, Inkook
    Kim, Ki Hyun
    Chiang, Yi-Hao
    Xie, Wei
    Lee, Yong Gu Gu
    Pajarillo, Raymone
    Rotolo, Antonia
    Shestova, Olga
    Hong, Seok Jae
    Abdel-Mohsen, Mohamed
    Wysocka, Maria
    Ballard, Hatcher J.
    Barrett, David M.
    Posey, Avery D.
    Powell, Daniel, Jr.
    Gill, Saar I.
    Schuster, Stephen J.
    Barta, Stefan K.
    Rook, Alain H.
    June, Carl H.
    Ruella, Marco
    BLOOD, 2020, 136
  • [10] Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells
    Ito, Yusuke
    Inoue, Satoshi
    Nakashima, Takahiro
    Zhang, Haosong
    Li, Yang
    Kasuya, Hitomi
    Matsukawa, Tetsuya
    Wu, Zhiwen
    Yoshikawa, Toshiaki
    Kataoka, Mirei
    Ishikawa, Tetsuo
    Kagoya, Yuki
    NUCLEIC ACIDS RESEARCH, 2024, 52 (01) : 141 - 153
12345